GCK and Hyperglycemia: These mutations result in reduced sensing of glucose by the pancreatic beta cell, so individuals with GCK-MODY regulate glucose at a higher set-point (fasting plasma glucose 5.5–8 mmol/l [10]) and have stable, mild hyperglycaemia throughout life [11].